Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism-Reference-Cited by-同舟云学术

Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism

Published:2019-08-01 Issue:8 Volume:179 Page:1034
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Kitahara Cari M.¹,Berrington de Gonzalez Amy¹,Bouville Andre¹,Brill Aaron B.²,Doody Michele M.¹,Melo Dunstana R.³,Simon Steven L.⁴,Sosa Julie A.⁵,Tulchinsky Mark⁶,Villoing Daphnée¹,Preston Dale L.⁷

Affiliation:

1. Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

2. Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee

3. Melohill Technology LLC, Rockville, Maryland

4. Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

5. Department of Surgery, University of California, San Francisco, San Francisco

6. Department of Radiology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey

7. Hirosoft International, Eureka, California

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/article-pdf/179/8/1034/17754756/jamainternal_kitahara_2019_oi_190030.pdf

Reference39 articles.

1. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.;Ross;Thyroid,2016

2. Cancer mortality following treatment for adult hyperthyroidism.;Ron;JAMA,1998